blenrep
glaxosmithkline (ireland) limited - belantamab mafodotin - Множествена миелома - Антинеопластични средства - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
jemperli
glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.
xevudy
glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - Имунни серуми и имуноглобулини - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.
lindynette 20 75 micrograms/20 micrograms coated tablets
gedeon richter ltd. - Гестоден и Этинилэстрадиол - 75 micrograms/20 micrograms coated tablets
zerlinda 4 mg/100 ml solution for infusion
4 mg/100 ml solution for infusion
clindavasin v 20 mg/g vaginal cream
20 mg/g vaginal cream
clindamycin hameln 150 mg/ml solution for injection/infusion
150 mg/ml solution for injection/infusion
clindavasin d 10 mg/ml cutaneous solution
10 mg/ml cutaneous solution
clindavasin duo 10 mg/g+50 mg/g gel
10 mg/g+50 mg/g gel
clindavasin duo 10 mg/g+30 mg/g gel
10 mg/g+30 mg/g gel